Literature DB >> 155499

The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells.

I Heron, M Hokland, A Møller-Larsen, K Berg.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 155499     DOI: 10.1016/0008-8749(79)90232-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  7 in total

1.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

2.  Enhancement of human ADCC with interferon.

Authors:  R Warren; D Kalamasz; R Storb
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

3.  Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A.

Authors:  I Kimber; T Bakács; M Moore
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

4.  Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.

Authors:  S Einhorn; H Blomgren; H Strander; J Wasserman
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Decreased antibody-dependent cellular cytotoxicity in minimal change nephrotic syndrome.

Authors:  C Y Lin
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

6.  Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

Authors:  M J Smyth; J R Ortaldo; Y Shinkai; H Yagita; M Nakata; K Okumura; H A Young
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

7.  Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation.

Authors:  O Ichimura; S Suzuki; Y Sugawara; T Osawa
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.